TCBWMS
REGN icon

Texas Capital Bank Wealth Management Services’s Regeneron Pharmaceuticals REGN Stock Holding History

Texas Capital Bank Wealth Management Services’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$238K Sell
308
-9
-3% -$6.89K 0.01% 312
2025
Q4 		$245K Buy
+317
New +$215K 0.01% 289

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Texas Capital Bank Wealth Management Services's REGN Position: Q1 2026 in Review

Texas Capital Bank Wealth Management Services reduced its Regeneron Pharmaceuticals (REGN) stake by 2.8% in Q1 2026, selling an estimated $6.89K and leaving 308 shares worth $238K. The position accounts for 0.01% of the portfolio, ranked #312.

Texas Capital Bank Wealth Management Services first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. The position peaked at $245K in Q4 2025. 1,393 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Texas Capital Bank Wealth Management Services held 308 shares of Regeneron Pharmaceuticals worth $238K as of Q1 2026.
  • Texas Capital Bank Wealth Management Services sold 9 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $6.89K.
  • Regeneron Pharmaceuticals made up 0.01% of Texas Capital Bank Wealth Management Services's portfolio in Q1 2026, its #312 holding.
  • Texas Capital Bank Wealth Management Services first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • Texas Capital Bank Wealth Management Services's Regeneron Pharmaceuticals position peaked at $245K in Q4 2025.
  • 1,393 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Texas Capital Bank Wealth Management Services's 13F filing for Q1 2026, filed 11 May 2026.